Cas no for 50-78-2,Acetylsalicylic acid ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

Home > CAS No. Inquiry > 50-78-2

50-78-2

[CAS Name] Acetylsalicylic acid

[Formula] C9H8O4

Search Products Post Sourcing Request

Basica Info

[CAS Name]Acetylsalicylic acid
[Alias]o-Acetylsalicylic acid 2-Acetoxybenzoic acid; 2-Acetoxybenzoic acid~Aspirin; aspirin usp; Aspirin; Acetoxybenzoic acid; Metronidazolum; 2-(acetyloxy)benzoic acid; 2-(acetyloxy)benzoate
[Number]50-78-2
[EINECS]200-064-1
[Formula]C9H8O4
[Molecular weight]180.15

[Melting point]136-140℃
[Boiling point]321.4°C at 760 mmHg
[Density]0.000124mmHg at 25°C
[Flash point]131.1°C

50-78-2 Suppliers

Company

Main Products

CISEN PHARMACEUTICAL CO.,LTD.

Aspirin enteric-coated tablets, which inhibit platelet aggregation, can be used to prevent the formation of blood clots after transient ischemic attacks, myocardial infarction, artificial heart valves and venous fistula or other surgery.The drug is an antiplatelet drug used for the treatment and prevention of patients with cardiovascular and cerebrovascular diseases or patients with high risk of cardiovascular and cerebrovascular diseases.

Specification： 100mg

Send Inquiry

Qingdao Qingmei Biotech Co.,Ltd

Usage
：Is the application of the earliest, most widely and most common Antipyretic &Analgesics Respiratory system &others drugs. Has the pharmacological effect of antipyretic, analgesic, anti-inflammatory, anti wind gentle anti platelet aggregation and other aspects of the play, rapid efficacy, efficacy sure,

Send Inquiry